22 related articles for article (PubMed ID: 8251884)
1. Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients.
Carlo-Stella C; Mangoni L; Piovani G; Garau D; Almici C; Rizzoli V
Blood; 1994 Mar; 83(5):1373-80. PubMed ID: 7509656
[TBL] [Abstract][Full Text] [Related]
2. Biological and chemical selection of Ph-negative clones.
Carlo-Stella C; Mangoni L; Piovani G; Garau D; Almici C; Rizzoli V
Stem Cells; 1993 Oct; 11 Suppl 3():77-82. PubMed ID: 8298479
[TBL] [Abstract][Full Text] [Related]
3. In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte--macrophage colony-stimulating factor.
Carlo-Stella C; Mangoni L; Piovani G; Almici C; Garau D; Caramatti C; Rizzoli V
Bone Marrow Transplant; 1991 Oct; 8(4):265-73. PubMed ID: 1756324
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow purging with mafosfamide--a critical survey.
Sindermann H; Peukert M; Hilgard P
Blut; 1989 Nov; 59(5):432-41. PubMed ID: 2684298
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell purging and positive selection of hematopoietic stem cells.
Gee AP
J Clin Apher; 1992; 7(3):135-7. PubMed ID: 1363101
[No Abstract] [Full Text] [Related]
8. Pharmacological bone marrow purging in autologous transplantation: focus on the cyclophosphamide derivatives.
Murgo AJ; Weinberger BB
Crit Rev Oncol Hematol; 1993 Feb; 14(1):41-60. PubMed ID: 8373540
[No Abstract] [Full Text] [Related]
9. Fractionation of chronic myelogenous leukemia marrow cells by stroma adherence: implications for marrow purging.
Rizzoli V; Mangoni L; Piovani G; Garau D; Caramatti C; Almici C; Carlo-Stella C
Leuk Lymphoma; 1993; 11 Suppl 1():109-12. PubMed ID: 8251884
[TBL] [Abstract][Full Text] [Related]
10. The potential role of amifostine (Ethyol) in haematological malignancies.
Gorin NC
Eur J Cancer; 1996; 32A Suppl 4():S31-9. PubMed ID: 8976820
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
